• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:梁亚冰,苏秀兰.甘草次酸逆转肿瘤多药耐药机制的研究进展[J].中国现代应用药学,2019,36(9):1151-1154.
LIANG Yabing,SU Xiulan.Research Progress on Glycyrrhetinic Acid Reversal of Multidrug Resistance in Tumor[J].Chin J Mod Appl Pharm(中国现代应用药学),2019,36(9):1151-1154.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2123次   下载 1801 本文二维码信息
码上扫一扫!
分享到: 微信 更多
甘草次酸逆转肿瘤多药耐药机制的研究进展
梁亚冰, 苏秀兰
内蒙古医科大学附属医院临床医学研究中心, 呼和浩特 010050
摘要:
甘草次酸属五环三萜类化合物,是中药甘草的重要活性成分,具有抗炎、抗病毒、抗溃疡、免疫调节等广泛的药理活性,近年来发现甘草次酸具有广谱的抗肿瘤作用,其抗肿瘤作用机制也得到了广泛研究。肿瘤多药耐药机制十分复杂,且目前在肿瘤的临床治疗中,仍然是化疗所面临的障碍和挑战。甘草次酸具有药理活性好,低毒性的优点,已经展现出对肿瘤多药耐药的逆转作用,具有在多种化疗药物引起的化学抵抗中成为化疗增敏剂的潜力。本文论述了肿瘤多药耐药的发生机制及甘草次酸逆转肿瘤多药耐药机制研究进展。
关键词:  甘草次酸  逆转  肿瘤  多药耐药
DOI:10.13748/j.cnki.issn1007-7693.2019.09.026
分类号:R285.5
基金项目:国家自然科学基金项目(81660468);内蒙古医科大学青年创新基金项目(YKD2017QNCX046)
Research Progress on Glycyrrhetinic Acid Reversal of Multidrug Resistance in Tumor
LIANG Yabing, SU Xiulan
Clinical Medical Research Center of the Affiliated Hospital, Inner Mongolia Medical University, Huhoot 010050, China
Abstract:
Glycyrrhetinic acid(GA) is belong to pentacyclic triterpene which is a major active ingredient in licorice, a famous traditional Chinese medicine. It has the effect of anti-inflammation, anti-virus, anti-ulcer and immune regulation. In recent years, it has been found that GA also has high broad spectrum anti-tumor activity, and its anti-tumor mechanism has attracted a great deal of attention. The mechanism of multidrug resistance(MDR) is very complex, and in current, MDR is still the obstacles and challenges of chemotherapy in clinical treatment of tumors. GA has the advantages of good pharmacological activity and low toxicity. The latest research shows that GA can reverse the multidrug resistance of tumor, but also can become a chemosensitizer in chemical resistance caused by various chemotherapy drugs. This paper discusses the mechanism of MDR, and the research progress of GA in reversing the multidrug resistance is reviewed in this paper.
Key words:  glycyrrhetinic acid  reversal  tumor  multidrug resistance
扫一扫关注本刊微信